UY30082A1 - Forma cristalina de 1-(1-metiletil)-4`-((2-fluoro-4-metoxifenil)metil)-5`- metil-1h-pirazol-3`-o-b-d-glucopiranosido, un metodo para su preparacion y el uso de la misma para preparar medicamentos - Google Patents
Forma cristalina de 1-(1-metiletil)-4`-((2-fluoro-4-metoxifenil)metil)-5`- metil-1h-pirazol-3`-o-b-d-glucopiranosido, un metodo para su preparacion y el uso de la misma para preparar medicamentosInfo
- Publication number
- UY30082A1 UY30082A1 UY30082A UY30082A UY30082A1 UY 30082 A1 UY30082 A1 UY 30082A1 UY 30082 A UY30082 A UY 30082A UY 30082 A UY30082 A UY 30082A UY 30082 A1 UY30082 A1 UY 30082A1
- Authority
- UY
- Uruguay
- Prior art keywords
- methyl
- glucopyranoside
- fluoro
- preparation
- same
- Prior art date
Links
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07H—SUGARS; DERIVATIVES THEREOF; NUCLEOSIDES; NUCLEOTIDES; NUCLEIC ACIDS
- C07H17/00—Compounds containing heterocyclic radicals directly attached to hetero atoms of saccharide radicals
- C07H17/02—Heterocyclic radicals containing only nitrogen as ring hetero atoms
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/70—Carbohydrates; Sugars; Derivatives thereof
- A61K31/7042—Compounds having saccharide radicals and heterocyclic rings
- A61K31/7052—Compounds having saccharide radicals and heterocyclic rings having nitrogen as a ring hetero atom, e.g. nucleosides, nucleotides
- A61K31/7056—Compounds having saccharide radicals and heterocyclic rings having nitrogen as a ring hetero atom, e.g. nucleosides, nucleotides containing five-membered rings with nitrogen as a ring hetero atom
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P13/00—Drugs for disorders of the urinary system
- A61P13/12—Drugs for disorders of the urinary system of the kidneys
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P27/00—Drugs for disorders of the senses
- A61P27/02—Ophthalmic agents
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P27/00—Drugs for disorders of the senses
- A61P27/02—Ophthalmic agents
- A61P27/12—Ophthalmic agents for cataracts
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P3/00—Drugs for disorders of the metabolism
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P3/00—Drugs for disorders of the metabolism
- A61P3/04—Anorexiants; Antiobesity agents
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P3/00—Drugs for disorders of the metabolism
- A61P3/08—Drugs for disorders of the metabolism for glucose homeostasis
- A61P3/10—Drugs for disorders of the metabolism for glucose homeostasis for hyperglycaemia, e.g. antidiabetics
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
- A61P9/08—Vasodilators for multiple indications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
- A61P9/10—Drugs for disorders of the cardiovascular system for treating ischaemic or atherosclerotic diseases, e.g. antianginal drugs, coronary vasodilators, drugs for myocardial infarction, retinopathy, cerebrovascula insufficiency, renal arteriosclerosis
Abstract
La invencinn se refiere a una forma cristalina de 1`-(1-metiletil)-4`-((2-fluoro-4-metoxifenil)metil-5`-meton-1H-pirazol-3N-B-D-glucopirannsido, a un mctodo para la preparacinn de la misma, ase como al uso de la misma para preparar medicamentos
Applications Claiming Priority (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
EP06000483 | 2006-01-11 |
Publications (1)
Publication Number | Publication Date |
---|---|
UY30082A1 true UY30082A1 (es) | 2007-08-31 |
Family
ID=35953998
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
UY30082A UY30082A1 (es) | 2006-01-11 | 2007-01-05 | Forma cristalina de 1-(1-metiletil)-4`-((2-fluoro-4-metoxifenil)metil)-5`- metil-1h-pirazol-3`-o-b-d-glucopiranosido, un metodo para su preparacion y el uso de la misma para preparar medicamentos |
Country Status (19)
Country | Link |
---|---|
US (2) | US7524822B2 (es) |
EP (1) | EP1976859A1 (es) |
JP (1) | JP4936234B2 (es) |
KR (1) | KR20090012205A (es) |
CN (1) | CN101370816A (es) |
AR (1) | AR058962A1 (es) |
AU (1) | AU2007204368A1 (es) |
BR (1) | BRPI0706375A2 (es) |
CA (1) | CA2635203A1 (es) |
EA (1) | EA200801663A1 (es) |
EC (1) | ECSP088501A (es) |
IL (1) | IL192655A0 (es) |
NO (1) | NO20082395L (es) |
NZ (1) | NZ570311A (es) |
PE (1) | PE20071237A1 (es) |
TW (1) | TW200745149A (es) |
UY (1) | UY30082A1 (es) |
WO (1) | WO2007080170A1 (es) |
ZA (1) | ZA200804151B (es) |
Families Citing this family (30)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
EP1550668A4 (en) * | 2002-10-04 | 2008-10-01 | Kissei Pharmaceutical | PYRAZOLE DERIVATIVE, MEDICINAL COMPOSITION COMPRISING THE DERIVATIVE, MEDICINAL USE THEREOF, AND INTERMEDIATE ENTERING THE PRODUCTION THEREOF |
EP2025674A1 (de) | 2007-08-15 | 2009-02-18 | sanofi-aventis | Substituierte Tetrahydronaphthaline, Verfahren zu ihrer Herstellung und ihre Verwendung als Arzneimittel |
US8399418B2 (en) * | 2007-12-27 | 2013-03-19 | Kissei Pharmaceutical Co., Ltd. | Monosebacate of pyrazole derivative |
WO2009128421A1 (ja) * | 2008-04-16 | 2009-10-22 | キッセイ薬品工業株式会社 | ピラゾール誘導体の1/2フマル酸塩 |
WO2010003624A2 (en) | 2008-07-09 | 2010-01-14 | Sanofi-Aventis | Heterocyclic compounds, processes for their preparation, medicaments comprising these compounds, and the use thereof |
WO2010068601A1 (en) | 2008-12-08 | 2010-06-17 | Sanofi-Aventis | A crystalline heteroaromatic fluoroglycoside hydrate, processes for making, methods of use and pharmaceutical compositions thereof |
WO2011023754A1 (en) | 2009-08-26 | 2011-03-03 | Sanofi-Aventis | Novel crystalline heteroaromatic fluoroglycoside hydrates, pharmaceuticals comprising these compounds and their use |
WO2011107494A1 (de) | 2010-03-03 | 2011-09-09 | Sanofi | Neue aromatische glykosidderivate, diese verbindungen enthaltende arzneimittel und deren verwendung |
EP2582709B1 (de) | 2010-06-18 | 2018-01-24 | Sanofi | Azolopyridin-3-on-derivate als inhibitoren von lipasen und phospholipasen |
US8530413B2 (en) | 2010-06-21 | 2013-09-10 | Sanofi | Heterocyclically substituted methoxyphenyl derivatives with an oxo group, processes for preparation thereof and use thereof as medicaments |
TW201221505A (en) | 2010-07-05 | 2012-06-01 | Sanofi Sa | Aryloxyalkylene-substituted hydroxyphenylhexynoic acids, process for preparation thereof and use thereof as a medicament |
TW201215387A (en) | 2010-07-05 | 2012-04-16 | Sanofi Aventis | Spirocyclically substituted 1,3-propane dioxide derivatives, processes for preparation thereof and use thereof as a medicament |
TW201215388A (en) | 2010-07-05 | 2012-04-16 | Sanofi Sa | (2-aryloxyacetylamino)phenylpropionic acid derivatives, processes for preparation thereof and use thereof as medicaments |
KR101019079B1 (ko) * | 2010-12-28 | 2011-03-07 | 최점미 | 돌침대용 온열 제어장치 |
US8901114B2 (en) | 2011-03-08 | 2014-12-02 | Sanofi | Oxathiazine derivatives substituted with carbocycles or heterocycles, method for producing same, drugs containing said compounds, and use thereof |
WO2012120054A1 (de) | 2011-03-08 | 2012-09-13 | Sanofi | Di- und trisubstituierte oxathiazinderivate, verfahren zu deren herstellung, ihre verwendung als medikament sowie sie enthaltendes arzneimittel und deren verwendung |
EP2683704B1 (de) | 2011-03-08 | 2014-12-17 | Sanofi | Verzweigte oxathiazinderivate, verfahren zu deren herstellung, ihre verwendung als medikament sowie sie enthaltendes arzneimittel und deren verwendung |
US8871758B2 (en) | 2011-03-08 | 2014-10-28 | Sanofi | Tetrasubstituted oxathiazine derivatives, method for producing them, their use as medicine and drug containing said derivatives and the use thereof |
EP2683699B1 (de) | 2011-03-08 | 2015-06-24 | Sanofi | Di- und trisubstituierte oxathiazinderivate, verfahren zu deren herstellung, ihre verwendung als medikament sowie sie enthaltendes arzneimittel und deren verwendung |
WO2013037390A1 (en) | 2011-09-12 | 2013-03-21 | Sanofi | 6-(4-hydroxy-phenyl)-3-styryl-1h-pyrazolo[3,4-b]pyridine-4-carboxylic acid amide derivatives as kinase inhibitors |
WO2013045413A1 (en) | 2011-09-27 | 2013-04-04 | Sanofi | 6-(4-hydroxy-phenyl)-3-alkyl-1h-pyrazolo[3,4-b]pyridine-4-carboxylic acid amide derivatives as kinase inhibitors |
PT2981269T (pt) | 2013-04-04 | 2023-10-10 | Boehringer Ingelheim Vetmedica Gmbh | Tratamento de distúrbios metabólicos em animais equinos |
CN111494357A (zh) | 2013-12-17 | 2020-08-07 | 勃林格殷格翰动物保健有限公司 | 猫科动物中代谢紊乱的治疗 |
MX2016009421A (es) * | 2014-01-23 | 2016-09-16 | Boehringer Ingelheim Vetmedica Gmbh | Tratamiento de trastornos metabolicos en animales caninos. |
JP6372560B2 (ja) * | 2014-02-28 | 2018-08-15 | 住友化学株式会社 | ピラゾール化合物の製造方法 |
HUE050095T2 (hu) | 2014-04-01 | 2020-11-30 | Boehringer Ingelheim Vetmedica Gmbh | Anyagcsere-rendellenességek kezelése lófélékben |
EP3197429A1 (en) | 2014-09-25 | 2017-08-02 | Boehringer Ingelheim Vetmedica GmbH | Combination treatment of sglt2 inhibitors and dopamine agonists for preventing metabolic disorders in equine animals |
CN105061322B (zh) * | 2015-07-27 | 2018-07-24 | 北京颖泰嘉和生物科技股份有限公司 | N-取代的3-羟基吡唑化合物的制备方法 |
EP3341024A1 (en) | 2015-08-27 | 2018-07-04 | Boehringer Ingelheim Vetmedica GmbH | Liquid pharmaceutical compositions comprising sglt-2 inhibitors |
US20230381101A1 (en) | 2022-05-25 | 2023-11-30 | Boehringer Ingelheim Vetmedica Gmbh | Aqueous pharmaceutical compositions comprising sglt-2 inhibitors |
Family Cites Families (26)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
PL203124B1 (pl) | 1999-08-31 | 2009-08-31 | Kissei Pharmaceutical | Pochodne glukopiranozyloksypirazolu, kompozycja farmaceutyczna je zawierająca i związki pośrednie |
EP1338603B1 (en) | 2000-11-02 | 2010-01-20 | Ajinomoto Co., Inc. | Novel pyrazole derivatives and diabetes remedies containing the same |
ES2326158T3 (es) | 2000-12-28 | 2009-10-02 | Kissei Pharmaceutical Co., Ltd. | Derivados de glucopiranosiloxipirazol y su utilizacion como medicamentos. |
DE60230591D1 (de) | 2001-02-26 | 2009-02-12 | Kissei Pharmaceutical | Glykopyranosyloxypyrazolderivate und deren medizinische verwendung |
AU2002338643A1 (en) | 2001-04-10 | 2002-10-28 | Millennium Pharmaceuticals, Inc. | 68723, sodium/glucose cotransporter family members and uses therefor |
CA2672001A1 (en) * | 2001-04-27 | 2002-11-07 | Ajinomoto Co., Inc. | N-substituted pyrazole-o-glycoside derivatives and therapeutic agent for diabetes containing the same |
EP1400529A4 (en) | 2001-05-30 | 2007-12-19 | Kissei Pharmaceutical | GLUCOPYRANOSYLOXYPYRAZOLE DERIVATIVE, MEDICINAL COMPOSITION CONTAINING THE SAME, AND MEDICINAL AND INTERMEDIARY USE THEREOF |
JP4115105B2 (ja) | 2001-07-02 | 2008-07-09 | 協和醗酵工業株式会社 | ピラゾール誘導体 |
WO2003020737A1 (en) | 2001-09-05 | 2003-03-13 | Bristol-Myers Squibb Company | O-pyrazole glucoside sglt2 inhibitors and method of use |
CA2484306A1 (en) | 2002-04-26 | 2003-11-06 | Katsumi Maezono | Prophylactic and therapeutic agent of diabetes mellitus |
US7956041B2 (en) | 2002-04-26 | 2011-06-07 | Ajinomoto Co., Inc. | Prophylactic and therapeutic agent of diabetes mellitus |
ITBO20020050U1 (it) | 2002-05-13 | 2003-11-13 | Netpack S R L | Contenitore per prodotti ortofrutticoli |
CA2494179C (en) | 2002-08-08 | 2012-04-24 | Kissei Pharmaceutical Co., Ltd. | Pyrazole derivative, medicinal composition containing the same, medicinal use thereof, and intermediate for production thereof |
JP2004137245A (ja) | 2002-08-23 | 2004-05-13 | Kissei Pharmaceut Co Ltd | ピラゾール誘導体、それを含有する医薬組成物、その医薬用途及びその製造中間体 |
WO2004019958A1 (ja) | 2002-08-27 | 2004-03-11 | Kissei Pharmaceutical Co., Ltd. | ピラゾール誘導体、それを含有する医薬組成物及びその医薬用途 |
EP1550668A4 (en) | 2002-10-04 | 2008-10-01 | Kissei Pharmaceutical | PYRAZOLE DERIVATIVE, MEDICINAL COMPOSITION COMPRISING THE DERIVATIVE, MEDICINAL USE THEREOF, AND INTERMEDIATE ENTERING THE PRODUCTION THEREOF |
CN1744916A (zh) | 2002-12-04 | 2006-03-08 | 橘生药品工业株式会社 | 预防和治疗高血糖所导致的疾病 |
EP1609799A4 (en) | 2003-04-01 | 2008-10-29 | Taisho Pharmaceutical Co Ltd | HETEROARYL-5-THIO-BETA-D-GLUCOPYRANOSIDE DERIVATIVES AND AGENTS AGAINST DIABETES THEREOF |
US7439232B2 (en) | 2003-04-01 | 2008-10-21 | Taisho Pharmaceutical Co., Ltd. | Heteroaryl 5-thio-β-D-glucopyranoside derivatives and therapeutic agents for diabetes containing the same |
EP1637539B1 (en) | 2003-06-20 | 2012-01-18 | Kissei Pharmaceutical Co., Ltd. | Pyrazole derivative, drug composition containing the same and production intermediate therefor |
CA2539032A1 (en) | 2003-08-26 | 2005-03-10 | Boehringer Ingelheim International Gmbh | Glucopyranosyloxy-pirazoles, drugs containing said compounds the use and production method thereof |
US7375090B2 (en) | 2003-08-26 | 2008-05-20 | Boehringer Ingelheim International Gmbh | Glucopyranosyloxy-pyrazoles, pharmaceutical compositions containing these compounds, the use thereof and processed for the preparation thereof |
AU2006271653A1 (en) | 2005-07-22 | 2007-01-25 | Boehringer Ingelheim International Gmbh | Processes for preparing pyrazole-o-glycoside derivatives and novel intermediates of said processes |
UY29694A1 (es) | 2005-07-28 | 2007-02-28 | Boehringer Ingelheim Int | Metodos para prevenir y tratar trastornos metabolicos y nuevos derivados de pirazol-o-glucosido |
PE20080251A1 (es) | 2006-05-04 | 2008-04-25 | Boehringer Ingelheim Int | Usos de inhibidores de dpp iv |
US20080020987A1 (en) | 2006-07-20 | 2008-01-24 | Waldemar Pfrengle | Processes for preparing pyrazole-O-glycoside derivatives and novel intermediates of said processes |
-
2007
- 2007-01-05 UY UY30082A patent/UY30082A1/es not_active Application Discontinuation
- 2007-01-09 PE PE2007000017A patent/PE20071237A1/es not_active Application Discontinuation
- 2007-01-10 US US11/621,859 patent/US7524822B2/en not_active Expired - Fee Related
- 2007-01-10 TW TW096100941A patent/TW200745149A/zh unknown
- 2007-01-10 BR BRPI0706375-0A patent/BRPI0706375A2/pt not_active IP Right Cessation
- 2007-01-10 AU AU2007204368A patent/AU2007204368A1/en not_active Abandoned
- 2007-01-10 WO PCT/EP2007/050209 patent/WO2007080170A1/en active Application Filing
- 2007-01-10 NZ NZ570311A patent/NZ570311A/en unknown
- 2007-01-10 CN CNA2007800030344A patent/CN101370816A/zh active Pending
- 2007-01-10 EA EA200801663A patent/EA200801663A1/ru unknown
- 2007-01-10 KR KR1020087019563A patent/KR20090012205A/ko not_active Application Discontinuation
- 2007-01-10 EP EP07703756A patent/EP1976859A1/en not_active Withdrawn
- 2007-01-10 AR ARP070100090A patent/AR058962A1/es unknown
- 2007-01-10 CA CA002635203A patent/CA2635203A1/en not_active Abandoned
- 2007-01-10 JP JP2008549026A patent/JP4936234B2/ja not_active Expired - Fee Related
-
2008
- 2008-05-14 ZA ZA200804151A patent/ZA200804151B/xx unknown
- 2008-05-27 NO NO20082395A patent/NO20082395L/no not_active Application Discontinuation
- 2008-06-04 EC EC2008008501A patent/ECSP088501A/es unknown
- 2008-07-07 IL IL192655A patent/IL192655A0/en unknown
-
2009
- 2009-03-16 US US12/404,442 patent/US7838500B2/en not_active Expired - Fee Related
Also Published As
Publication number | Publication date |
---|---|
JP4936234B2 (ja) | 2012-05-23 |
BRPI0706375A2 (pt) | 2011-03-22 |
US7524822B2 (en) | 2009-04-28 |
PE20071237A1 (es) | 2008-01-15 |
WO2007080170A1 (en) | 2007-07-19 |
CA2635203A1 (en) | 2007-07-19 |
NO20082395L (no) | 2008-07-31 |
AR058962A1 (es) | 2008-03-05 |
US7838500B2 (en) | 2010-11-23 |
IL192655A0 (en) | 2009-02-11 |
JP2009522340A (ja) | 2009-06-11 |
US20090181905A1 (en) | 2009-07-16 |
EA200801663A1 (ru) | 2009-02-27 |
US20070244176A1 (en) | 2007-10-18 |
TW200745149A (en) | 2007-12-16 |
NZ570311A (en) | 2010-05-28 |
KR20090012205A (ko) | 2009-02-02 |
ZA200804151B (en) | 2009-10-28 |
ECSP088501A (es) | 2008-07-30 |
EP1976859A1 (en) | 2008-10-08 |
CN101370816A (zh) | 2009-02-18 |
AU2007204368A1 (en) | 2007-07-19 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
UY30082A1 (es) | Forma cristalina de 1-(1-metiletil)-4`-((2-fluoro-4-metoxifenil)metil)-5`- metil-1h-pirazol-3`-o-b-d-glucopiranosido, un metodo para su preparacion y el uso de la misma para preparar medicamentos | |
BRPI0818893B8 (pt) | compostos de tropano, suas composições farmacêuticas, seus usos e método in vitro de inibição de hsp90 em uma célula | |
PA8791801A1 (es) | Compuestos de pirazol | |
CR10369A (es) | Pyrimidine derivatives as pi3k inhibitors | |
ECSP109856A (es) | Derivados de oxadiazol y su uso como potenciadores de los receptores metabotrópicos de glutamato - 842 | |
ECSP11011181A (es) | Compuestos orgánicos | |
DK1711481T4 (da) | Krystallinsk monohydrat som kinaseinhibitorer | |
MY153921A (en) | Aminopyrazole derivatives | |
CL2007003791A1 (es) | Compuestos derivados de piperidina, inhibidores de la proteina quinasa; composicion farmaceutica que comprende a dichos compuestos; y su uso para inhibir el crecimiento celular anormal. | |
DK1931346T3 (da) | Trazodonsammensætning til indgivelse en gang om dagen | |
SMAP200800048A (it) | Derivati pirimidinici utilizzati come inibitori dip13-chinasi | |
CL2012001348A1 (es) | Sal cristalina de hemitartrato del compuesto genz-112638, inhibidor de glucosilceramida sintetasa; composición farmacéutica que la comprende;y su uso en el tratamiento de la enfermedad de gaucher y enfermedad de fabry. | |
ZA200904138B (en) | Substituted spirochromanone derivatives as acc inhibitors | |
DK1763517T3 (da) | Pyrimidinderivater som 11beta-HSD1-inhibitorer | |
CY1106902T1 (el) | Κρυσταλλικη μορφη μηλεϊνικης ασεναπινης | |
DK1948643T3 (da) | 3-Alkyl-5-(4-alkyl-5-oxo-tetrahydrofuran-2-yl)pyrrolidin-2-on-derivater som mellemprodukter i syntese af renininhibitorer | |
SMAP200900065A (it) | Derivati ciclizzati come inibitori di eg-5 | |
DK1740569T3 (da) | Imidazol-derivater som TAFla-inhibitorer | |
SG148179A1 (en) | Benzyltriazolone compounds as non-nucleoside reverse transcriptase inhibitors | |
AU2007306104A1 (en) | Hydrobenzamide derivatives as inhibitors of Hsp90 | |
GT200800251A (es) | Nitrilos espirociclicos como inhibidores de proteasa | |
UA99787C2 (en) | Lactams as beta secretase inhibitors | |
DK2049480T3 (da) | 2-arylindolderivater som mPGES-1-hæmmere | |
ES2530578T3 (es) | Cristales y cristales reticulados de Proteína A y métodos de uso de los mismos | |
CR10787A (es) | Substituted pyrazole and triazole compounds as ksp inhibitors |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
109 | Application deemed to be withdrawn |
Effective date: 20170526 |